Clinical Trial Update: Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial [Phase 2]

View source ↗

Summary

This document describes a single-arm Phase II trial evaluating Hybrid Arc Palliative Radiation Therapy (HART) for palliative radiotherapy in patients with metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of Vermont Medical Center | Conditions: Palliative Radiotherapy, Metastatic Cancer (Different Solid Tumour Types) | Phase 2 | Status: RECRUITING